Chat about Tissue Regenix Group accounts information. See how Tissue Regenix Group is performing financially.

Tissue Regenix Group Accounts Summary


Date of Accounts 20232022202120202019
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement31-12-202331-12-202231-12-202131-12-202031-12-2019
Revenue29.4924.4819.7516.4713.03
Operating Profit / Loss-0.39-2.01-4.45-12.58-7.20
Net Interest-1.27-0.82-0.69-0.57-0.47
Pre Tax Profit-1.67-2.83-5.14-13.15-7.66
Post Tax Profit-1.66-2.60-4.99-12.46-7.11
Profit for the Period-1.66-2.60-4.99-12.46-7.11
Equity Holders of Parent Company-1.71-2.69-4.79-12.47-6.97
Minority Interests0.060.10-0.19n/a-0.13
      
Continuing EPS     
Earnings per Share (Basic)-2.43 USX-3.83 USX-7.00 USX-28.00 USX-60.00p
Earnings per Share (Diluted)-2.43 USX-3.83 USX-7.00 USX-28.00 USX-60.00p
Earnings per Share (Adjusted)-2.43 USX-3.83 USX-7.00 USX-28.00 USX-60.00p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-2.43 USX-3.83 USX-7.00 USX-28.00 USX-60.00p
Earnings per Share (Diluted)-2.43 USX-3.83 USX-7.00 USX-28.00 USX-60.00p
Earnings per Share (Adjusted)-2.43 USX-3.83 USX-7.00 USX-28.00 USX-60.00p
      
Dividend per Sharen/a USDn/a USDn/a USDn/a USDn/ap
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31-12-202331-12-202231-12-202131-12-202031-12-2019
Non-Current Assets     
Intangible Assets15.1315.0615.0615.3018.00
Property, Plant and Equipment9.028.949.107.752.36
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assetsn/an/an/an/an/a
Total Non-Current Assets24.1524.0024.1623.0520.36
      
Current Assets     
Inventories10.3610.889.729.604.18
Trade and Other Receivables3.734.804.103.592.54
Cash at Bank and in Hand4.655.957.7112.972.38
Current Asset Investmentsn/an/an/an/an/a
Other Current Assets0.350.400.531.121.03
Total Current Assets19.0922.0322.0627.2810.14
      
Other Assetsn/an/an/an/an/a
Total Assets43.2446.0446.2250.3330.50
      
Current Liabilities     
Borrowings0.641.130.120.350.17
Other Current Liabilities4.095.514.244.082.94
Total Current Liabilities4.736.644.364.433.12
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings8.758.477.836.872.12
Provisions0.400.520.640.760.67
Other Non-Current Liabilitiesn/an/an/an/an/a
Total Non-Current Liabilities9.158.998.477.632.79
      
Net Assets29.3630.4033.3938.2724.59
      
Capital and Reserves     
Share Capital15.9515.9515.9515.955.86
Share Premium Account134.25134.18134.17134.1786.40
Other Reserves3.713.254.654.553.89
Retained Earnings-123.76-122.13-120.43-115.64-70.94
Shareholders Funds30.1531.2534.3439.0325.21
      
Minority Interests / Other Equity-0.80-0.85-0.95-0.76-0.61
Total Equity29.3630.4033.3938.2724.59
      
 31-12-202331-12-202231-12-202131-12-202031-12-2019
Operating Margin-1.34%-8.21%-22.53%-76.38%-55.26%
Return on Capital Employed-1.64%-7.89%-16.53%-40.64%-75.27%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/an/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share0.20 USD0.22 USD0.26 USD0.33 USD9.35p